glutathione disulfide has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, K; He, Z; Ma, J; Wang, Y; Zheng, K | 1 |
| Degiannis, E; Greyling, D; Hatzitheofilou, C; Levy, RD; Oosthuizen, MM | 1 |
2 other study(ies) available for glutathione disulfide and Esophageal Neoplasms
| Article | Year |
|---|---|
Sulforaphane Inhibits Autophagy and Induces Exosome-Mediated Paracrine Senescence via Regulating mTOR/TFE3.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Cellular Senescence; DNA Damage; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Exosomes; Glutathione Disulfide; Humans; Isothiocyanates; Lysosomes; Paracrine Communication; Reactive Oxygen Species; Sulfoxides; TOR Serine-Threonine Kinases | 2020 |
Glutathione-linked enzymes in benign and malignant oesophageal tissue.
Topics: Esophageal Neoplasms; Female; gamma-Glutamyltransferase; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Male; Middle Aged; Mutation; Oxidation-Reduction | 1999 |